Surgery Partners EBITDA Margin 2013-2024 | SGRY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surgery Partners (SGRY) over the last 10 years. The current EBITDA margin for Surgery Partners as of September 30, 2024 is .
| Surgery Partners EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.98B | $0.49B | 16.39% |
| 2024-06-30 | $2.89B | $0.49B | 16.90% |
| 2024-03-31 | $2.79B | $0.49B | 17.50% |
| 2023-12-31 | $2.74B | $0.46B | 16.77% |
| 2023-09-30 | $2.72B | $0.45B | 16.61% |
| 2023-06-30 | $2.66B | $0.44B | 16.60% |
| 2023-03-31 | $2.61B | $0.42B | 16.25% |
| 2022-12-31 | $2.54B | $0.47B | 18.59% |
| 2022-09-30 | $2.44B | $0.48B | 19.82% |
| 2022-06-30 | $2.38B | $0.47B | 19.75% |
| 2022-03-31 | $2.31B | $0.45B | 19.54% |
| 2021-12-31 | $2.22B | $0.41B | 18.57% |
| 2021-09-30 | $2.16B | $0.40B | 18.41% |
| 2021-06-30 | $2.10B | $0.35B | 16.77% |
| 2021-03-31 | $1.93B | $0.34B | 17.35% |
| 2020-12-31 | $1.86B | $0.29B | 15.54% |
| 2020-09-30 | $1.83B | $0.26B | 14.22% |
| 2020-06-30 | $1.79B | $0.29B | 16.47% |
| 2020-03-31 | $1.86B | $0.30B | 16.17% |
| 2019-12-31 | $1.83B | $0.32B | 17.64% |
| 2019-09-30 | $1.81B | $0.20B | 10.86% |
| 2019-06-30 | $1.79B | $0.18B | 10.08% |
| 2019-03-31 | $1.78B | $0.17B | 9.34% |
| 2018-12-31 | $1.77B | $0.16B | 8.75% |
| 2018-09-30 | $1.74B | $0.29B | 16.49% |
| 2018-06-30 | $1.61B | $0.23B | 14.50% |
| 2018-03-31 | $1.47B | $0.22B | 14.95% |
| 2017-12-31 | $1.34B | $0.22B | 16.12% |
| 2017-09-30 | $1.19B | $0.19B | 16.10% |
| 2017-06-30 | $1.16B | $0.24B | 20.29% |
| 2017-03-31 | $1.17B | $0.25B | 21.63% |
| 2016-12-31 | $1.15B | $0.24B | 21.12% |
| 2016-09-30 | $1.10B | $0.20B | 17.95% |
| 2016-06-30 | $1.06B | $0.20B | 18.68% |
| 2016-03-31 | $1.00B | $0.19B | 18.54% |
| 2015-12-31 | $0.96B | $0.19B | 19.69% |
| 2015-06-30 | $0.53B | $0.12B | 22.70% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.263B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |